Stock listing
Hanover:HS2 Henry Schein, Inc. Aktie
German listing (Hanover) of Henry Schein, Inc. · home listing NASDAQ:HSIC
Follow Henry Schein, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:HSIC
$83.52 USD -2.17 (-2.5%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:HSIC
- Day range
- $83.20 – $86.31 USDNov 20, 2026
- Volume
- 1.31M sharesNov 20, 2026
- Market cap
- $9.23B USDAt the close on Nov 20, 2026 · price × 110.5M shares outstanding
- 52-week range
- $68.70 – $92.18 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $112.1M USDMedian day 1.09M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:HSIC · Home | $83.52 USD | -2.17 (-2.5%) | 1,308,838 | $85.13 | $86.31 | $83.20 | $85.69 | Close on Nov 20, 2026 |
| LSE:0L3C | $84.65 USD | +0.57 (+0.7%) | 141 | $84.97 | $86.18 | $84.65 | $84.08 | Close on Nov 20, 2026 |
| B3:H1SI34 | 249.12 BRL | 0.00 (0.0%) | — | 249.12 | 249.12 | 249.12 | 249.12 | Close on Nov 19, 2026 |
| Frankfurt:HS2 | €76.50 EUR | -1.00 (-1.3%) | — | €76.50 | €76.50 | €76.50 | €77.50 | Close on Nov 20, 2026 |
| Dusseldorf:HS2 | €76.50 EUR | +0.50 (+0.7%) | — | €75.00 | €77.00 | €75.00 | €76.00 | Close on Nov 20, 2026 |
| Hamburg:HS2 | €77.50 EUR | +1.00 (+1.3%) | — | €75.50 | €77.50 | €75.50 | €76.50 | Close on Nov 20, 2026 |
| Munich:HS2 | €75.50 EUR | -3.00 (-3.8%) | — | €76.25 | €76.25 | €75.50 | €78.50 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:HSIC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $83.52 | -2.17 | -2.5% | $85.13 | $86.31 | $83.20 | 1,308,838 | |
| $85.69 | +2.75 | +3.3% | $82.36 | $86.11 | $82.18 | 2,083,073 | |
| $82.94 | -2.02 | -2.4% | $84.15 | $85.56 | $82.80 | 1,517,856 | |
| $84.96 | -1.26 | -1.5% | $85.70 | $86.22 | $83.89 | 1,711,266 | |
| $86.22 | +0.08 | +0.1% | $86.27 | $86.65 | $85.73 | 2,184,625 | |
| $86.14 | -2.28 | -2.6% | $88.58 | $89.17 | $86.11 | 1,085,649 | |
| $88.42 | -0.32 | -0.4% | $88.28 | $88.80 | $87.00 | 1,005,478 | |
| $88.74 | +0.33 | +0.4% | $88.12 | $89.61 | $87.92 | 981,209 | |
| $88.41 | +2.36 | +2.7% | $87.50 | $88.89 | $86.26 | 1,761,915 | |
| $86.05 | +0.74 | +0.9% | $83.22 | $87.57 | $83.02 | 1,375,006 | |
| $85.31 | -2.93 | -3.3% | $89.68 | $89.68 | $84.78 | 2,097,939 | |
| $88.24 | +5.74 | +7.0% | $84.12 | $88.48 | $84.06 | 3,904,637 | |
| $82.50 | -4.12 | -4.8% | $82.37 | $86.87 | $81.05 | 4,417,634 | |
| $86.62 | +1.74 | +2.0% | $85.45 | $87.28 | $85.38 | 2,501,792 | |
| $84.88 | -1.56 | -1.8% | $86.57 | $86.95 | $84.49 | 1,195,426 | |
| $86.44 | +1.48 | +1.7% | $85.65 | $86.44 | $85.23 | 924,678 | |
| $84.96 | +0.71 | +0.8% | $84.10 | $85.57 | $83.97 | 934,462 | |
| $84.25 | -0.26 | -0.3% | $84.62 | $85.60 | $83.75 | 709,804 | |
| $84.51 | -0.45 | -0.5% | $85.01 | $85.43 | $84.12 | 937,891 | |
| $84.96 | -1.04 | -1.2% | $85.50 | $86.05 | $84.43 | 836,768 | |
| $86.00 | +0.99 | +1.2% | $84.81 | $86.26 | $84.81 | 2,075,100 | |
| $85.01 | +0.33 | +0.4% | $84.68 | $85.34 | $83.85 | 1,263,900 | |
| $84.68 | +0.71 | +0.8% | $84.55 | $85.64 | $84.23 | 1,231,700 | |
| $83.97 | -2.41 | -2.8% | $86.32 | $87.36 | $83.92 | 1,317,200 | |
| $86.38 | -0.61 | -0.7% | $87.38 | $88.13 | $85.85 | 1,178,800 | |
| $86.99 | +1.43 | +1.7% | $86.78 | $87.33 | $86.24 | 963,200 | |
| $85.56 | +0.53 | +0.6% | $85.19 | $86.25 | $84.56 | 1,116,100 | |
| $85.03 | +0.80 | +0.9% | $84.76 | $85.32 | $83.87 | 717,000 | |
| $84.23 | +0.22 | +0.3% | $84.16 | $84.92 | $83.89 | 955,300 | |
| $84.01 | -0.62 | -0.7% | $84.11 | $85.13 | $83.48 | 1,087,400 | |
| $84.63 | +0.97 | +1.2% | $79.95 | $84.66 | $79.37 | 2,675,900 | |
| $83.66 | -1.18 | -1.4% | $84.79 | $85.64 | $83.56 | 1,312,000 | |
| $84.84 | +0.61 | +0.7% | $84.78 | $86.40 | $84.31 | 1,421,100 | |
| $84.23 | -0.65 | -0.8% | $85.48 | $85.51 | $83.42 | 1,904,300 | |
| $84.88 | -0.05 | -0.1% | $85.18 | $85.56 | $83.45 | 1,132,900 | |
| $84.93 | +0.96 | +1.1% | $83.96 | $85.28 | $83.30 | 1,025,600 | |
| $83.97 | -1.00 | -1.2% | $84.98 | $85.33 | $83.86 | 883,500 | |
| $84.97 | -1.02 | -1.2% | $85.51 | $85.86 | $84.39 | 978,800 | |
| $85.99 | -0.38 | -0.4% | $85.88 | $86.78 | $85.37 | 984,300 | |
| $86.37 | +0.84 | +1.0% | $85.53 | $86.58 | $85.43 | 1,202,200 | |
| $85.53 | +0.48 | +0.6% | $84.50 | $85.92 | $84.38 | 1,381,500 | |
| $85.05 | -2.38 | -2.7% | $86.89 | $87.98 | $84.80 | 1,119,600 | |
| $87.43 | +2.23 | +2.6% | $85.93 | $87.64 | $85.58 | 1,070,500 | |
| $85.20 | +0.36 | +0.4% | $85.25 | $85.80 | $84.40 | 1,347,600 | |
| $84.84 | -0.20 | -0.2% | $84.84 | $85.96 | $84.41 | 2,220,200 | |
| $85.04 | -1.73 | -2.0% | $87.01 | $87.10 | $84.15 | 1,801,000 | |
| $86.77 | -0.75 | -0.9% | $87.52 | $88.32 | $86.44 | 1,018,100 | |
| $87.52 | -1.41 | -1.6% | $88.93 | $88.93 | $87.26 | 1,551,500 | |
| $88.93 | +0.57 | +0.6% | $88.57 | $89.12 | $87.65 | 818,400 | |
| $88.36 | +1.06 | +1.2% | $88.54 | $88.79 | $87.36 | 713,800 | |
| $87.30 | -0.67 | -0.8% | $88.20 | $88.22 | $87.11 | 1,536,200 | |
| $87.97 | -0.89 | -1.0% | $88.14 | $88.92 | $87.65 | 768,100 | |
| $88.86 | -0.95 | -1.1% | $89.50 | $89.99 | $88.71 | 711,800 | |
| $89.81 | -1.05 | -1.2% | $89.91 | $90.54 | $89.65 | 887,900 | |
| $90.86 | +0.47 | +0.5% | $90.68 | $91.69 | $89.56 | 679,300 | |
| $90.39 | +1.87 | +2.1% | $89.02 | $91.36 | $88.61 | 859,400 | |
| $88.52 | -1.28 | -1.4% | $89.80 | $90.15 | $88.00 | 718,000 | |
| $89.80 | +0.28 | +0.3% | $88.93 | $90.00 | $88.16 | 1,153,600 | |
| $89.52 | -0.76 | -0.8% | $90.54 | $91.09 | $89.47 | 796,000 | |
| $90.28 | -0.10 | -0.1% | $90.30 | $91.39 | $89.61 | 784,800 | |
| $90.38 | +0.73 | +0.8% | $89.97 | $90.67 | $89.49 | 697,200 | |
| $89.65 | +0.14 | +0.2% | $89.19 | $89.84 | $88.74 | 819,500 | |
| $89.51 | +1.01 | +1.1% | $88.50 | $89.71 | $87.67 | 669,200 | |
| $88.50 | +0.04 | 0.0% | $88.74 | $89.11 | $88.19 | 758,800 | |
| $88.46 | -0.83 | -0.9% | $89.00 | $89.69 | $88.41 | 865,700 |
Splits
3 splits since 2005 · NASDAQ:HSIC · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 51-for-40 | Split | |
| 2-for-1 | Split | |
| 2-for-1 | Split |
- Ticker
- Hanover:HS2
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- Hanover
- Currency
- EUR
What changed lately
Latest news release · Nov 16, 2026
Henry Schein Updates Presentation of Non-GAAP Financial Measures
Latest earnings call · Nov 3, 2026
Henry Schein (NASDAQ:HSIC) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 3, 2026
Q3 2026 Earnings Presentation
Earnings · 22 slides
Latest news
Henry Schein Updates Presentation of Non-GAAP Financial Measures
Nov 16, 2026
Closed $84.96 (-1.5%) on Nov 16, 2026
CareQuest and Henry Schein Launch the BRIDGE Health Network to Advance Dental-Medical Integration
Nov 10, 2026
Closed $88.74 (+0.4%) on Nov 10, 2026
Henry Schein to Participate in Upcoming Investor Conferences in November and December
Nov 5, 2026
Closed $85.31 (-3.3%) on Nov 5, 2026
Henry Schein Reports Strong 2026 Third Quarter and Raises FY2026 Guidance
Nov 3, 2026
Closed $82.50 (-4.8%) on Nov 3, 2026
Henry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8: 00 a.m. ET
Oct 20, 2026
Closed $84.68 (+0.8%) on Oct 20, 2026
Henry Schein Announces Chief Financial Officer Leadership Transition
Oct 8, 2026
Closed $84.63 (+1.2%) on Oct 8, 2026
Henry Schein Cares Marks 25 Years of Helping Health Happen®
Sep 30, 2026
Closed $83.97 (-1.2%) on Sep 30, 2026
Henry Schein to Participate in Upcoming Investor Conference in September
Sep 8, 2026
Closed $88.86 (-1.1%) on Sep 8, 2026
Henry Schein Reports Strong Second Quarter 2026 Financial Results and Raises FY2026 Guidance
Aug 4, 2026
Closed $89.11 (+3.0%) on Aug 4, 2026
Henry Schein Announces Leadership Transitions
Jul 30, 2026
Closed $85.17 (-0.8%) on Jul 30, 2026
Henry Schein, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 34 in the last 12 months · 359 in all · newest Nov 16, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Nov 3, 2026
- Decks
- 45 decks · latest Nov 3, 2026
Where Henry Schein, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HSIC · Home listing | NASDAQ | United States | USD |
| BIVA:HSIC | BIVA | Mexico | MXN |
| BMV:HSIC | BMV | Mexico | MXN |
| LS Exchange:897961 | LS Exchange | Germany | EUR |
| gettex:HS2 | gettex | Germany | EUR |
| Milan:1HSIC | Milan | Italy | EUR |
| Lang & Schwarz:897961 | Lang & Schwarz | Germany | EUR |
| BOATS:HSIC | BOATS | United States | USD |
| LSE:0L3C | LSE | United Kingdom | USD |
| B3:H1SI34 | B3 | Brazil | BRL |
| Tradegate:HS2 | Tradegate | Germany | EUR |
| VIE:HSIC | Vienna | Austria | EUR |
| Frankfurt:HS2 | Frankfurt | Germany | EUR |
| Hanover:HS2 · This page | Hanover | Germany | EUR |
| BX Swiss:HS2 | BX Swiss | Switzerland | CHF |
| Dusseldorf:HS2 | Dusseldorf | Germany | EUR |
| Hamburg:HS2 | Hamburg | Germany | EUR |
| Munich:HS2 | Munich | Germany | EUR |
| Stuttgart:HS2 | Stuttgart | Germany | EUR |
Valuation
P/E 21.9× against a median of 31.8×: 5th lowest of 11 Health care services companies shown. Statements: 4 quarters to Sep 26, 2026 · price Nov 20, 2026
- Enterprise value
- $10.19B USD
- P/E
- 21.9×
- EV/sales
- 0.7×
- EV/EBITDA
- 9.8×
- Price/book
- 2.9×
- Gross margin
- 31.6%
- Operating margin
- 5.2%
- Net margin
- 3.1%
- Debt to equity
- 0.4×
- Beta vs S&P 500
- 0.60
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Henry Schein, Inc. · NASDAQ:HSIC | US$9.23B | US$10.19B | 21.9× | 0.7× | 9.8× | 2.9× | 3.1% | 0.4× | 0.60 |
| Max Healthcare Institute Ltd · NSE:MAXHEALTH | US$11.35B | US$11.69B | 76.2× | 11.8× | 44.1× | 9.3× | 15.1% | 0.3× | n/a |
| Fresenius Medical Care AG · XETR:FME | US$10.71B | US$21.03B | 11.9× | 1.0× | 5.3× | 0.8× | 4.2% | 0.8× | n/a |
| DaVita Inc. · NYSE:DVA | US$10.34B | US$20.54B | 11.2× | 1.4× | 7.3× | n/a | 6.5% | n/a | 0.01 |
| The Ensign Group, Inc. · NASDAQ:ENSG | US$10.29B | US$10.09B | 25.8× | 1.8× | 16.0× | 4.0× | 7.0% | 0.1× | 0.12 |
| Manipal Health Enterprises Limited · NSE:MANIPALHOS | US$9.97B | US$10.74B | 141× | 9.1× | 37.2× | 11.0× | 6.0% | 1.2× | n/a |
| Bangkok Dusit Medical Services Public Co. Ltd. · SET:BDMS | US$9.66B | US$9.68B | 21.1× | 2.9× | 12.8× | 3.2× | 13.7% | 0.1× | n/a |
| Universal Health Services, Inc. · NYSE:UHS | US$9.27B | US$14.81B | 6.3× | 0.8× | 5.6× | 1.2× | 8.0% | 0.8× | 0.20 |
| Ramsay Health Care Limited · ASX:RHC | US$8.24B | US$15.03B | 37.8× | 1.2× | 10.3× | 2.5× | 1.8% | 2.2× | n/a |
| Aster DM Healthcare Ltd. · NSE:ASTERDM | US$7.32B | US$7.32B | 213× | 13.9× | 70.8× | 14.0× | 6.5% | 0.0× | n/a |
| Hinge Health, Inc. · NYSE:HNGE | US$7.24B | US$6.95B | 43.0× | 8.7× | 44.9× | 24.2× | 21.0% | 0.0× | 1.18 |
| Median of the others | US$9.82B | US$11.22B | 31.8× | 2.3× | 14.4× | 4.0× | 6.8% | 0.3× | 0.16 |
Forecasts
4 strong buy · 4 buy · 7 hold · 1 strong sell · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.
- Price target
- 96.87 USD · Analysts' mean
- EPS, year to Dec 2026
- 5.45 · 11 analysts
- Revenue, year to Dec 2026
- 13.84B · 15 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Andrea Albertini | Chief Executive Officer, Global Distribution & Technology |
| Ronald N. South | Senior Vice President, Chief Financial Officer |
| Deborah Derby | The Honey Baked Ham Company, LLC, and Former President, Carrols Restaurant Group, Inc. |
| Kelly Murphy | Senior Vice President & General Counsel |
| Graham Stanley | Vice President, Investor Relations and Strategic Financial Project Officer |
| Tim Vassilakos | Vice President, Global Corporate Communications |
| Christine Sheehy | Senior Vice President, Chief Human Resources Officer |
| Mark E. Mlotek | Executive Vice President, Chief Strategic Officer |
| Mohamad Ali | Senior Vice President and Head of IBM Consulting, IBM Corporation |
| Reed V. Tuckson | Managing Director of Tuckson Health Connections, LLC; Former Executive Vice President and Chief of Medical Affairs, UnitedHealth Group; and Co-Founder and Board Chairman of the Coalition For Trust in |
Board
| Director | Role |
|---|---|
| William K. Dan Daniel | Independent Chairman of the Board, Director |
| Anne H. Margulies | Director |
| Carole T. Faig | Director |
| Kurt P. Kuehn | Director |
| Max Lin | Partner, Kohlberg Kravis Roberts & Co. L.P. (KKR) |
| Mohamad Ali | Senior Vice President and Head of IBM Consulting, IBM Corporation |
| Philip Laskawy | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Henry Schein (NASDAQ:HSIC) Q3 2026 Earnings Call | Tue, Nov 03, 2026 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q2 2026 Earnings Call | Tue, Aug 04, 2026 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q1 2026 Earnings Call | Tue, May 05, 2026 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q4 2025 Earnings Call | Tue, Feb 24, 2026 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q3 2025 Earnings Call | Tue, Nov 04, 2025 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q2 2025 Earnings Call | Tue, Aug 05, 2025 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q1 2025 Earnings Call | Mon, May 05, 2025 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q4 2024 Earnings Call | Tue, Feb 25, 2025 · 8:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q3 2024 Earnings Call | Tue, Nov 05, 2024 · 10:00 AM ET | Replay |
| Henry Schein (NASDAQ:HSIC) Q2 2024 Earnings Call | Tue, Aug 06, 2024 · 10:00 AM ET | Replay |
All 23 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 3, 2026 · Before open | −4.8% |
| Q2 2026 | Aug 4, 2026 · Before open | +3.0% |
| Q1 2026 | May 5, 2026 · Before open | +3.3% |
| Q4 2025 | Feb 18, 2026 | −0.5% |
| Q3 2025 | Nov 4, 2025 · Before open | +10.8% |
| Q2 2025 | Aug 5, 2025 · Before open | −7.4% |
| Q1 2025 | May 5, 2025 · Before open | +2.0% |
| Q4 2024 | Feb 25, 2025 · Before open | −2.3% |
| Q3 2024 | Nov 5, 2024 · Before open | −4.6% |
| Q2 2024 | Aug 6, 2024 · Before open | −8.1% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 7, 2024 · Before open | +3.9% |
| Q4 2023 | Feb 27, 2024 · Before open | −3.4% |
| Q3 2023 | Nov 13, 2023 · Before open | +5.3% |
| Q2 2023 | Aug 7, 2023 · Before open | −2.8% |
| Q1 2023 | May 9, 2023 · Before open | −6.2% |
| Q4 2022 | Feb 16, 2023 · Before open | −6.6% |
| Q3 2022 | Nov 1, 2022 · Before open | +4.8% |
| Q2 2022 | Aug 2, 2022 · Before open | −3.7% |
| Q1 2022 | May 3, 2022 · Before open | +2.0% |
| Q4 2021 | Feb 15, 2022 · Before open | +8.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 22 slides | Nov 3, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 21 slides | Aug 4, 2026 |
| Investor Presentation (August 2026) | Investor deck | 40 slides | Aug 4, 2026 |
| Investor Presentation (May 2026) | Investor deck | 40 slides | May 5, 2026 |
| Investor Presentation (February 2026) | Investor deck | 40 slides | Feb 24, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 21 slides | Feb 24, 2026 |
| J.P. Morgan Healthcare Conference 2026 | Conference | 8 slides | Jan 13, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 21 slides | Nov 4, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 44 slides | Aug 5, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 22 slides | May 5, 2025 |
All 45 decks
Financings
| Raise | Date |
|---|---|
| Strategic investment of common shares Closed: US$250M raised Buyers: KKR (approximately 12% of the common shares) | May 16, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.2B | 12.7B | 12.3B | 12.6B | 12.4B | 10.1B | 9.99B | 13.2B | 12.5B |
| Cost of revenue | 9.08B | 8.66B | 8.48B | 8.82B | 8.73B | 7.30B | 6.89B | 6.51B | 6.14B |
| Gross profit | 4.11B | 4.02B | 3.86B | 3.83B | 3.67B | 2.82B | 3.09B | 2.91B | 2.75B |
| Research and development | 0 | ||||||||
| Selling, general and administrative | 3.08B | 3.03B | 2.96B | 2.77B | 2.63B | 2.09B | 2.36B | 2.22B | 2.07B |
| Operating income | 653.0M | 621.0M | 615.0M | 747.0M | 852.0M | 535.0M | 718.3M | 600.6M | 669.8M |
| Depreciation and amortization | 311.0M | 297.0M | 248.0M | 212.0M | 210.0M | 186.0M | 184.9M | 143.6M | 133.9M |
| EBITDA | 964.0M | 918.0M | 863.0M | 959.0M | 1.06B | 721.0M | 903.2M | 744.2M | 803.6M |
| Interest expense | 150.0M | 131.0M | 87.0M | 35.0M | 27.0M | 41.0M | 50.8M | 76.0M | 51.1M |
| Income before tax | 533.0M | 513.0M | 542.0M | 721.0M | 831.0M | 500.0M | 680.3M | 536.8M | 629.8M |
| Income tax | 126.0M | 128.0M | 120.0M | 170.0M | 198.0M | 95.0M | 159.5M | 107.4M | 309.0M |
| Net income | 398.0M | 390.0M | 416.0M | 538.0M | 631.0M | 404.0M | 694.7M | 535.9M | 406.3M |
| Earnings per share, basic | 3.29 | 3.07 | 3.18 | 3.95 | 4.51 | 2.83 | 4.70 | 3.51 | 2.59 |
| Earnings per share, diluted | 3.27 | 3.05 | 3.16 | 3.91 | 4.45 | 2.82 | 4.65 | 3.49 | 2.57 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 156.0M | 122.0M | 171.0M | 117.0M | 118.0M | 421.0M | 106.1M | 56.9M | 174.7M | 158.0M |
| Short-term investments | 0 | |||||||||
| Receivables | 1.65B | 1.48B | 1.86B | 1.44B | 1.45B | 1.42B | 1.25B | 1.17B | 1.52B | |
| Inventory | 2.00B | 1.81B | 1.81B | 1.96B | 1.86B | 1.51B | 1.43B | 1.42B | 1.93B | 1.93B |
| Current assets | 4.46B | 3.98B | 4.49B | 3.99B | 3.84B | 3.79B | 3.23B | 4.18B | 4.03B | 4.09B |
| Property, plant and equipment | 667.0M | 366.5M | 342.0M | 329.6M | 314.2M | 0 | 375.0M | |||
| Goodwill | 4.21B | 3.89B | 3.88B | 2.89B | 2.85B | 2.50B | 2.46B | 2.08B | 2.30B | 1.55B |
| Total assets | 11.2B | 10.2B | 10.6B | 8.61B | 8.48B | 7.77B | 7.15B | 8.50B | 7.81B | 7.86B |
| Accounts payable | 1.15B | 962.0M | 1.02B | 1.00B | 1.05B | 1.01B | 880.3M | 785.8M | 0 | 1.15B |
| Current liabilities | 3.23B | 2.80B | 2.68B | 2.22B | 2.31B | 2.28B | 2.04B | 3.22B | 2.78B | 2.83B |
| Long-term debt | 2.31B | 1.83B | 1.94B | 1.04B | 811.0M | 515.8M | 622.9M | 980.3M | 0 | 907.8M |
| Total debt | 3.11B | 2.54B | 2.35B | 1.15B | 873.0M | 183.2M | 133.8M | 1.94B | 924.4M | 924.4M |
| Total liabilities | 6.42B | 5.38B | 5.42B | 3.94B | 3.81B | 3.46B | 3.23B | 4.65B | 4.15B | 4.21B |
| Shareholders' equity | 3.25B | 3.39B | 3.65B | 3.45B | 3.42B | 3.35B | 3.00B | 2.96B | 3.66B | 2.81B |
| Shares outstanding | 115.8M | 124.2M | 129.2M | 131.8M | 137.1M | 142.5M | 143.4M | 151.4M | 153.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 712.0M | 848.0M | 500.0M | 602.0M | 710.0M | 599.0M | 654.1M | 684.7M | 545.5M |
| Capital spending | -139.0M | -148.0M | -147.0M | -96.0M | -79.0M | -49.0M | -76.2M | -71.3M | -62.4M |
| Free cash flow | 573.0M | 700.0M | 353.0M | 506.0M | 631.0M | 550.0M | 577.9M | 613.4M | 483.1M |
| Cash from investing | -400.0M | -430.0M | -1.14B | -276.0M | -677.0M | -115.0M | -424.4M | -193.0M | -342.3M |
| Cash from financing | -188.0M | -510.0M | 701.0M | -315.0M | -333.0M | -187.0M | -216.0M | -603.8M | -112.6M |
| Dividends paid | -2.10B | -30.0M | -7.47M | -14.3M | -148.1M | -17.5M | -29.1M | ||
| Share buybacks | -850.0M | -385.0M | -250.0M | -485.0M | -401.0M | -74.0M | -525.0M | -200.0M | -450.0M |
| Change in cash | 34.0M | -49.0M | 54.0M | -1.00M | -303.0M | 315.1M | 25.9M | -94.4M | 224.6M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 16, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 12, 2026 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Nov 6, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 3, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 3, 2026 | Results | SEC |
| 8-K · Current report | Oct 8, 2026 | Management or board change | SEC |
| 8-K · Current report | Sep 22, 2026 | Material contract | SEC |
| 4 · Change in ownership | Sep 9, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 14, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 6, 2026 | Big-stake notice | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Aug 4, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 4, 2026 | Results | SEC |
| 8-K · Current report | Jul 30, 2026 | Management or board change | SEC |
| 144 · Notice of proposed sale | Jun 30, 2026 | Other filings | SEC |
| 11-K · Annual report of an employee plan | Jun 18, 2026 | Annual report | SEC |
| 144 · Notice of proposed sale | Jun 16, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 15, 2026 | Insider trade | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 3 · Initial statement of ownership | May 28, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 8-K · Current report | May 22, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2026 | Insider trade | SEC |
| DEFA14A · Additional proxy material | May 12, 2026 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2026 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 8, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 8, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 8, 2026 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 20, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 19, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Mar 10, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 10, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 5, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 4, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 3 · Initial statement of ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 27, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 26, 2026 | Other filings | SEC |
| 10-K · Annual report | Feb 24, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 24, 2026 | Results | SEC |
| 8-K · Current report | Jan 12, 2026 | Management or board change | SEC |
| 8-K · Current report | Dec 23, 2025 | Management or board change | SEC |
| 8-K · Current report | Dec 23, 2025 | Material contract | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Dec 9, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 9, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 9, 2025 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Dec 3, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 21, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 17, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Nov 6, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 4, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 31, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 30, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 11, 2025 | Insider trade | SEC |
| 8-K · Current report | Sep 9, 2025 | Management or board change | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Aug 15, 2025 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 11, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Aug 8, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 5, 2025 | Results | SEC |
| 8-K · Current report | Jul 15, 2025 | Management or board change | SEC |
| UPLOAD · Letter from the SEC | Jul 8, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 2, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jun 24, 2025 | Other filings | SEC |
| 11-K · Annual report of an employee plan | Jun 20, 2025 | Annual report | SEC |
| 4 · Change in ownership | Jun 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2025 | Insider trade | SEC |
| CORRESP · Letter to the SEC | Jun 9, 2025 | Other filings | SEC |
| 8-K · Current report | Jun 9, 2025 | Material contract | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 2, 2025 | Insider trade | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 8-K · Current report | May 23, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | May 23, 2025 | Insider trade | SEC |
| CORRESP · Letter to the SEC | May 23, 2025 | Other filings | SEC |
| 3 · Initial statement of ownership | May 21, 2025 | Insider trade | SEC |
| UPLOAD · Letter from the SEC | May 20, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 16, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 16, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 16, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | May 16, 2025 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | May 16, 2025 | Meeting notice | SEC |
| 8-K · Current report | May 16, 2025 | Material contract | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 8, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | May 6, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2025 | Results | SEC |
| DEFA14A · Additional proxy material | May 2, 2025 | Meeting notice | SEC |
| 8-K · Current report | May 2, 2025 | Material contract | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 25, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 17, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Apr 15, 2025 | Management or board change | SEC |
| ARS · Annual report to shareholders | Apr 9, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 9, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 9, 2025 | Meeting notice | SEC |
| 8-K · Current report | Apr 9, 2025 | Material contract | SEC |
| 4 · Change in ownership | Mar 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 20, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 19, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 19, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| SCHEDULE 13D · Big-stake notice | Mar 17, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 14, 2025 | Insider trade | SEC |
| 8-K · Current report | Mar 14, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 5, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
This page holds 200 of 1,001 filings. Open Filings
Cap table
Built by 6ix from Henry Schein, Inc.’s releases · as of Oct 26, 2026
- Common shares
- 110,538,542
- Fully diluted
- 110,538,542
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 110,538,542 | Oct 26, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 26, 2026 | 110,538,542 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Norman S Matthews Other companies: ThredUp Inc. (Director · Mar 25, 2021 – May 25, 2022 · Past); Grocery Outlet Holding Corp. (Director · Mar 30, 2019 – Dec 15, 2022 · Past); Party City Holdco Inc (Director · Apr 15, 2015 – Jun 13, 2022 · Past); Duff & Phelps Corp (Director · Oct 24, 2012 – Apr 23, 2013 · Past); Spectrum Brands Holdings, Inc. (Director · Jun 16, 2010 – Dec 2, 2020 · Past); Children's Place, Inc. (the) (Director · Mar 5, 2009 – Feb 9, 2024 · Past); Finlay Enterprises Inc (Director · Jan 30, 2006 – Nov 5, 2007 · Past); Progressive Corporation (the) (Director · Dec 31, 2005 – Mar 29, 2012 · Past) | Director · Mar 2, 2006 – Mar 31, 2016 · Past |
| Louis W Sullivan Other companies: United Therapeutics Corporation (Director · Since at least Jun 26, 2006); Emergent BioSolutions Inc. (Director · Nov 14, 2006 – Apr 30, 2025 · Past); ANI Pharmaceuticals, Inc. (Director · Mar 16, 2006 – Mar 30, 2012 · Past); Inhibitex Inc (Director · Feb 1, 2006 – Feb 1, 2007 · Past); 3M Company (Director · Dec 31, 2005 – May 9, 2006 · Past); The Cigna Group (Director · Dec 31, 2005 – Jun 1, 2006 · Past); Bristol-Myers Squibb Company (Director · Dec 30, 2005 – Mar 31, 2006 · Past) | Director · Mar 2, 2006 – Mar 31, 2016 · Past |
| Philip Laskawy Other companies: Covetrus Inc (Director · Feb 7, 2019 – Oct 13, 2022 · Past); Federal National Mortgage Association (Director · Sep 16, 2008 – Sep 16, 2008 · Past); Lazard, Inc. (Director · Jul 29, 2008 – Jun 1, 2022 · Past); Discover Financial Services (Director · Jun 14, 2007 – Apr 10, 2008 · Past); General Motors Company (Director · Dec 31, 2005 – Dec 31, 2012 · Past); Loews Corporation (Director · Dec 31, 2005 – Mar 1, 2023 · Past); Progressive Corporation (the) (Director · Dec 31, 2005 – Sep 14, 2007 · Past) | Director · Since at least Mar 2, 2006 |
| Robert J. Hombach Other companies: Seaport Therapeutics, Inc. (Director · Since at least Apr 30, 2026); Embecta Corp. (Director · Since at least Mar 20, 2022); BioMarin Pharmaceutical Inc. (Director · Since at least Sep 29, 2017); Aptinyx Inc (Director · Jun 20, 2018 – May 26, 2022 · Past); CarMax Inc (Director · Apr 1, 2018 – Jul 2, 2021 · Past); Baxalta Inc (EVP. CFO and COO · Jul 1, 2015 – Jun 3, 2016 · Past) | Director · Since at least Jan 29, 2025 |
| Shira Goodman Other companies: American Public Education, Inc. (Director · Since at least Oct 27, 2026); Burlington Stores, Inc. (Director · Since at least Jan 1, 2025); CBRE Group Inc (Director · Since at least May 17, 2019); CarMax Inc (Director · Since at least Oct 17, 2007); Staples Inc (CEO, Director · Feb 2, 2014 – Sep 12, 2017 · Past); Stride Rite Corp (Director · Mar 7, 2006 – Jun 5, 2007 · Past) | Director · May 31, 2018 – Mar 3, 2021 · Past |
| Karen N. Prange Other companies: Outset Medical, Inc. (Director · Since at least Jan 9, 2026); Embecta Corp. (Director · Since at least Apr 1, 2022); AtriCure, Inc. (Director · Since at least Dec 4, 2019); Nevro Corp (Director · Dec 17, 2019 – Apr 3, 2025 · Past); Cantel Medical Corp (Director · Oct 28, 2019 – Jun 2, 2021 · Past) | EVP&CEO Gl.AH.Med.Den.Sur.Grp · May 17, 2016 – Mar 2, 2018 · Past |
| Deborah Derby Other companies: Children's Place, Inc. (the) (CHIEF ADMINISTRATIVE OFFICER · Nov 12, 2021 – Nov 12, 2021 · Past); Carrols Restaurant Group Inc (President and CEO, Director · Jun 7, 2018 – May 16, 2024 · Past); Vitamin Shoppe Inc (Director · Jan 2, 2014 – Dec 16, 2019 · Past) | The Honey Baked Ham Company, LLC, and Former President, Carrols Restaurant Group, Inc. · Since at least Feb 9, 2021 |
| Joseph L Herring Other companies: Labcorp Holdings Inc. (CEO of Covance Drug Division · Feb 19, 2015 – Jul 31, 2015 · Past); Team Health Holdings Inc (Director · Nov 18, 2013 – May 20, 2016 · Past); Covance Inc (Chairman and CEO, Director · Feb 23, 2006 – Feb 19, 2015 · Past) | Director · Since at least May 31, 2016 |
| Max Lin Other companies: GMR Solutions Inc. (Director · Since at least May 13, 2026); BrightSpring Health Services, Inc. (Director · Since at least Jan 26, 2024); PRA Health Sciences Inc (Director · Nov 12, 2014 – Nov 12, 2014 · Past) | Partner, Kohlberg Kravis Roberts & Co. L.P. (KKR) · Since at least May 2, 2025 |
| Walter Siegel Other companies: MSC Industrial Direct Company, Inc. (SVP, Gen Counsel & Corp Sec · Since at least Jul 20, 2026); Covetrus Inc (Assistant Secretary, Director · Feb 4, 2019 – Feb 4, 2019 · Past); Standard Microsystems Corp (Sr. VP & General Counsel · Apr 21, 2006 – Aug 2, 2012 · Past) | Sr. VP & Chief Legal Officer · Oct 7, 2013 – Mar 14, 2025 · Past |
All 45 people
| Person | Seat |
|---|---|
| Barry J Alperin Other companies: Jefferies Financial Group Inc. (Director · Nov 26, 2018 – Mar 29, 2023 · Past); Fiesta Restaurant Group Inc (Director · Apr 28, 2016 – May 2, 2018 · Past) | Director · Mar 31, 2016 – Mar 16, 2022 · Past |
| Frederick M. Lowery Other companies: Thermo Fisher Scientific Inc (Executive Vice President · Since at least Apr 23, 2024); DuPont de Nemours, Inc. (Director · Since at least Nov 30, 2020) | CEO, Director · Since at least Mar 2, 2026 |
| Lawrence S Bacow Other companies: Loews Corporation (Director · Aug 9, 2011 – Mar 13, 2018 · Past); BXP, Inc. (Director · Mar 31, 2005 – Aug 20, 2012 · Past) | Director · Dec 1, 2014 – Mar 6, 2018 · Past |
| Mohamad Ali Other companies: iRobot Corporation (Director · Aug 17, 2015 – Jun 7, 2024 · Past); Carbonite Inc (CEO and President, Director · Dec 3, 2014 – Jun 17, 2019 · Past) | Senior Vice President and Head of IBM Consulting, IBM Corporation · Since at least Feb 9, 2021 |
| Steven Paladino Other companies: MSC Industrial Direct Company, Inc. (Lead Independent Director · Since at least Sep 24, 2015); Covetrus Inc (Director · Feb 4, 2019 – Oct 13, 2022 · Past) | Director · Mar 2, 2006 – Mar 1, 2024 · Past |
| William K. Daniel Other companies: Envista Holdings Corporation (Director · Sep 17, 2019 – Dec 18, 2019 · Past); Danaher Corporation (EVP · Dec 31, 2017 – Mar 4, 2020 · Past) | Director · Since at least May 16, 2025 |
| Anne H. Margulies Other companies: HarborOne Bancorp Inc (EVP, Chief Banking Officer · Since at least Jun 15, 2022) | Director · Since at least May 31, 2018 |
| Bridget A Ross Other companies: LeMaitre Vascular, Inc. (Director · Since at least Apr 28, 2020) | President, Global Medical Grp · Feb 14, 2017 – Mar 6, 2017 · Past |
| Mark E. Mlotek Other companies: Covetrus Inc (Director · Feb 4, 2019 – Feb 4, 2019 · Past) | Executive Vice President, Chief Strategic Officer · Since at least Mar 2, 2006 |
| Reed V. Tuckson Other companies: Adverum Biotechnologies Inc (Director · Since at least Jun 17, 2024) | Director · Since at least Mar 1, 2024 |
| Andrea Albertini | CEO, Global Dist. & Tech. · Since at least May 21, 2024 |
| Bradford C Connett | CEO, NA Distribution Group · Sep 15, 2021 – Mar 19, 2025 · Past |
| Bradley T Sheares | Director · Since at least Feb 22, 2023 |
| Carole T. Faig | Director · Since at least Dec 13, 2023 |
| Carol Raphael | Director · Aug 15, 2012 – May 21, 2025 · Past |
| Christine Sheehy | Senior Vice President, Chief Human Resources Officer · Since at least May 22, 2025 |
| David B Brous Jr | CEO, Strategic Business Group · Sep 15, 2021 – Jun 12, 2023 · Past |
| Donald J Kabat | Director · Mar 2, 2006 – Mar 6, 2018 · Past |
| E Dianne Rekow | Director · Mar 31, 2016 – Mar 16, 2022 · Past |
| Graham Stanley | Vice President, Investor Relations and Strategic Financial Project Officer · Since at least Jul 30, 2026 |
| James A Harding | SVP, Chief Technology Officer · May 16, 2016 – Mar 8, 2017 · Past |
| James P Breslawski | President · Dec 17, 2013 – Mar 14, 2025 · Past |
| Kelly Murphy | Senior Vice President & General Counsel · Since at least May 21, 2026 |
| Kurt P. Kuehn | Director · Since at least Mar 3, 2021 |
| Leonard A David | SVP, Chief Compliance Officer · Mar 2, 2006 – Mar 17, 2015 · Past |
| Lorelei McGlynn | SVP, Chief Human Res. Officer · May 13, 2013 – Sep 6, 2024 · Past |
| Michael S Ettinger | EVP & Chief Operating Officer · Since at least May 6, 2020 |
| Paul Brons | Director · Mar 2, 2006 – Mar 3, 2021 · Past |
| Peter M McCarthy | Pres., Global Animal Health · Jun 23, 2015 – Mar 13, 2017 · Past |
| Ronald N. South | SVP & Chief Financial Officer · Since at least Apr 29, 2022 |
| Scott Philip Serota | Director · Since at least Dec 7, 2021 |
| Stanley M Bergman | Director · Since at least May 9, 2025 |
| Thomas C Popeck | CEO, Henry Schein Products · Since at least Feb 12, 2025 |
| Tim Vassilakos | Vice President, Global Corporate Communications · Since at least Oct 8, 2026 |
| Tom Popeck | Henry Schein Products Group · Jul 15, 2025 – May 12, 2026 · Past |
Log in to ask 6ix AI your own questions about Henry Schein, Inc.